CagA

Delivery by the type IV secretion system#

The strongest mechanistic evidence represented in the vault connects CagA translocation to H. pylori's nickel-dependent NiFe Hydrogenase. Hydrogen oxidation supplies energy to the bacterium.

A review of nickel in microbial pathogenesis reports that hydrogenase-deletion mutants could not translocate CagA and did not induce gastric cancer in a Mongolian-gerbil model; isolates from patients with cancer also showed higher hydrogenase activity than isolates from patients with gastritis alone.^{[1]Role of Nickel in Microbial PathogenesisRobert J. Maier, Stéphane L. Benoit · 2019Open reference 1 ↓}

This is an indirect metal dependency. CagA is not described in these sources as a nickel-binding protein or metalloenzyme. Rather, Nickel supports hydrogenase maturation and bacterial metabolism, and that upstream system enables efficient CagA delivery.

The same distinction applies to dietary nickel: a small pilot study found higher H. pylori eradication with a low-nickel diet added to antibiotic therapy, but its proposed hydrogenase–CagA explanation is mechanistic interpretation rather than a direct measurement of CagA translocation in participants.^{[2]Nickel Free-Diet Enhances the Helicobacter pylori Eradication Rate: A Pilot StudyCampanale M, Nucera E, Ojetti V et al. · 2014Open reference 2 ↓}

Gastric carcinogenesis#

CagA provides a defined route by which a microbial virulence program can contribute to host carcinogenesis. In the animal-model evidence summarized above, disrupting the bacterial energy system prevented both CagA delivery and tumor induction.

This supports a pathway from nickel acquisition to hydrogenase activity, type IV secretion, CagA translocation, and gastric epithelial consequences.^{[1]Role of Nickel in Microbial PathogenesisRobert J. Maier, Stéphane L. Benoit · 2019Open reference 1 ↓}

That pathway should not be reduced to a single exposure equation. CagA status is one component of H. pylori pathogenicity; colonization density, duration, gastric location, host susceptibility, inflammation, diet, and other bacterial factors can alter the outcome.

Evidence that a strain is CagA-positive does not establish that a particular person will develop cancer.

What strain status and antibodies can show#

“CagA-positive” usually classifies an H. pylori strain or infection context; “CagA antibody” refers to a host immune marker of exposure. Neither measurement directly quantifies how much protein is being delivered into gastric cells at the time of sampling.

A two-sample Mendelian-randomization study tested genetically predicted antibody levels to several H. pylori proteins. It reported a very small association between overall H. pylori IgG and GERD risk, but no causal association for the CagA antibody individually.^{[3]Causal relationship between Helicobacter pylori antibodies and gastroesophageal reflux disease (GERD): A mendelian studyChen J, Zhang J, Ma X et al. · 2023Open reference 3 ↓}

This result concerns the studied GERD outcome and serologic instrument; it does not negate CagA's experimentally supported role in gastric virulence.

Associations beyond gastric cancer#

A cross-sectional gastric-microbiome study found H. pylori less often in erosive reflux disease than in comparison groups. The authors discussed reduced acid output, including proposed CagA-mediated effects on parietal cells and atrophic gastritis, as one possible explanation.

Because the design was cross-sectional, it cannot establish that CagA protects against reflux or that the proposed mechanism caused the observed pattern.^{[4]Sugihartono 2022 — Gastric Microbiota and H. pylori in GERDSugihartono · 2022Open reference 4 ↓}

A pancreatic-cancer microbiome review reported stronger associations for CagA-positive H. pylori strains than for H. pylori infection considered without strain qualification.

This is an epidemiologic association in a non-gastric cancer context, not evidence that CagA is delivered to pancreatic tissue or independently causes pancreatic cancer.^{[5]Role of the microbiome in occurrence, development and treatment of pancreatic cancerYicheng Wang, Gang Yang, Lei You et al. · 2019Open reference 5 ↓}

A gut-thyroid-axis review describes nucleotide-sequence similarity between CagA-positive H. pylori strains and thyroid peroxidase in a molecular-mimicry hypothesis.

The source is a narrative review and explicitly places microbiome-to-thyroid causation and therapeutic implications in an emerging-evidence category; the proposed similarity should not be treated as proof that CagA causes autoimmune thyroid disease.^{[6]Zhu et al. 2024 — Intestinal Microbiota Regulates the Gut-Thyroid Axis: The New Dawn of Improving Hashimoto ThyroiditisZhu X, Zhang C, Feng S et al. · 2024Open reference 6 ↓}